相关实验视频

Updated: Jul 5, 2025

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

针对FGF19-FGFR4通路用于胆固醇,代谢和癌症疾病

Xiaokun Li¹, Weiqin Lu², Alexei Kharitonenkov³

¹School of Pharmacological Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.

Journal of internal medicine

|January 12, 2024

概括

人体纤维细胞生长因子19 (FGF19) 调节胆酸合成和新陈代谢. FGF19类似物在治疗肝脏疾病和代谢障碍方面表现有前途,但潜在的瘤发生需要进一步研究.

科学领域:

内分泌学在内分泌学.
肝病学肝病学是一种肝病学.
在瘤学瘤学.

背景情况:

纤维细胞生长因子19 (FGF19) 是通过Farnesoid X受体和Klotho beta (KLB) /纤维细胞生长因子受体4 (FGFR4) 综合体的胆酸 (BA) 合成的关键调节者.
通过KLB和FGFR1-3信号传递,FGF19还影响葡萄糖,脂质和能量代谢.
FGF19信号的失调与胆固醇和代谢性肝病以及肝细胞癌 (HCC) 有关.

研究的目的:

审查针对FGF19-FGFR4通路的FGF19类似物和对抗剂的临床发展.
分析基于FGF19的药物的治疗潜力和安全问题,用于胆固醇,代谢和癌症疾病.
为了指导未来的研究和临床试验FGF19向治疗.

主要方法:

关于FGF19信号的临床前和临床研究的文献综述.
分析了涉及FGF19基药物的1/2期临床试验数据.
评估与FGF19和FGFR4信号相关的机械和安全数据.

主要成果:

在胆固醇和代谢疾病 (PBC,PSC,NASH) 的模型中,FGF19类似物有效降低BA水平并改善肝脏健康.
在临床前模型中,FGF19信号传递,特别是通过FGFR4,可以促进瘤发生和HCC发展.
临床试验显示,基于FGF19的药物在治疗PBC,PSC,NASH和HCC方面具有有希望的疗效.

结论:

基于FGF19的疗法在治疗肝脏疾病和代谢障碍方面具有显著的潜力.
仔细考虑FGF19-FGFR4通路在再生和瘤发生中的双重作用对于治疗开发至关重要.
需要进一步的研究和先进的试验来优化FGF19向治疗的安全性和有效性.

关键词:

联邦财政基金19年在FGFR4中.胆汁酸胆汁酸胆汁酸胆固醇的形成.肝细胞癌是肝细胞癌.没有酒精含量的型肝炎.

更多相关视频

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...